From April 4, 2023 to June 30, 2023, the company has repurchased 2,000,000 shares, representing 0.12% for CNY 72.2 million. With this, the company has completed the repurchase of 2,000,000 shares, representing 0.12% for CNY 72.2 million under the buyback announced on April 5, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.37 CNY | -1.13% | +2.16% | -51.64% |
06-26 | Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology | MT |
06-18 | Walvax Terminates Coronavirus Vaccine Trials Due to Mutations | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.64% | 2.5B | |
+6.58% | 41.61B | |
-11.57% | 33.32B | |
+79.15% | 28.8B | |
-14.73% | 15.61B | |
-6.00% | 13.27B | |
-12.55% | 11.46B | |
+166.50% | 10.06B | |
-54.80% | 9.09B | |
+4.19% | 8.9B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Tranche Update on Walvax Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 5, 2023.